Form 4 for ELTX Elicio Therapeutics, Inc.
Accepted 2024-11-29 00:00:00 ET · period of report 2024-11-26 · accession 0001601485-24-000105 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-29 | 2024-11-26 | ELTX | Venkatesan Jay | Dir | X - OptEx | $0.01 | +50.0K | 179.6K | +39% | +$500 |
| D | 2024-11-29 | 2024-11-26 | ELTX | Venkatesan Jay | Dir | X - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-26 | X | A | 50,000 | $0.01 | 179,581 | D | — | — | (F1) On November 26, 2024, the Reporting Person exercised a pre-funded warrant to purchase an aggregate of 50,000 shares of the Issuer's common stock. |
| 2 | Derivative | Warrant to Purchase Common Stock | 2024-11-26 | X | D | 50,000 | $0.00 | 0 | D | $0.01 · 2024-07-01 to — | 50,000 Common Stock | (F3) N/A |